DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Neogen Chemicals Limited — Press Release

NSE 1 hr ago·1 Nov 2026, 6:03 pm

Neogen Chemicals

Neogen Chemicals Limited filed a press release with the stock exchange, disclosing its unaudited financial results for the quarter and half‑year ended September 30, 2026. The figures are preliminary and have not yet been audited.

The release gives investors an early look at revenue, profit margins and cash‑flow trends for the chemical maker. Comparing these numbers with prior periods and market expectations can help gauge how the company’s product lines and pricing are performing.

Investors should watch for the audited results, any management commentary and guidance for the next quarter, as well as broader industry developments that could influence demand for Neogen’s chemicals.